Induction of humoural immunity is critical for clinical protection against malaria. More than 100 malaria vaccine candidates have been investigated at different developmental stages, but with limited
As progress towards malaria elimination continues, the challenge posed by the parasite species Plasmodium vivax has become more evident. In many regions co-endemic for P. vivax and Plasmodium falcipar
BackgroundMSP3 has been shown to induce protection against malaria in African children. The characterization of a family of Plasmodium falciparum merozoite surface protein 3 (MSP3) antigens sharing a
AMA1 peptide sequences and residue numbers were based on those of the P. falciparum clone FC27. Gene Bank ID 810891. Previously identified Class II AMA1 epitopes were distributed among peptide pools,
